Literature DB >> 6299867

Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.

Y Uchigata, H Yamamoto, H Nagai, H Okamoto.   

Abstract

Nicotinamide (10 mmol/kg) and 3-aminobenzamide (1.25 mmol/kg), poly(ADP-ribose) synthetase inhibitors, were injected intravenously to rats either 30 min before the intravenous administration of 12 mg/kg alloxan or 50 mg/kg streptozotocin ("pretreatment") or 5 min after the administration ("posttreatment"). Fifteen minutes after the injection of the diabetogenic agents, pancreatic islets were isolated from the rats and proinsulin synthesis was determined. Proinsulin synthesis was decreased in islets from rats treated with alloxan or streptozotocin. Pretreatment with poly(ADP-ribose) synthetase inhibitors was found to protect against alloxan- or streptozotocin-induced decrease in proinsulin synthesis. By posttreatment with poly(ADP-ribose) synthetase inhibitors, streptozotocin-induced decrease in proinsulin synthesis was also significantly reversed, whereas the decrease induced by alloxan was not.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299867     DOI: 10.2337/diab.32.4.316

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.

Authors:  P Masiello; T L Cubeddu; G Frosina; E Bergamini
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

2.  Long-term effects of exposure of pancreatic islets to nicotinamide in vitro on DNA synthesis, metabolism and B-cell function.

Authors:  S Sandler; A Andersson
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

3.  Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin-secreting cell line (RINr).

Authors:  B T Mossman; C M Ireland; M Filipak; S LeDoux; G L Wilson
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

4.  Protection of islet cells from inflammatory cell death in vitro.

Authors:  V Burkart; H Kolb
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

5.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

Authors:  S Schröder; W Palinski; G W Schmid-Schönbein
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 6.  CD38 autoimmunity: recent advances and relevance to human diabetes.

Authors:  A Antonelli; E Ferrannini
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

7.  Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells.

Authors:  F Horio; M Fukuda; H Katoh; M Petruzzelli; N Yano; C Rittershaus; S Bonner-Weir; M Hattori
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Nitric oxide generation and poly(ADP ribose) polymerase activation precede beta-cell death in rats with a single high-dose injection of streptozotocin.

Authors:  Ryuichi Wada; Soroku Yagihashi
Journal:  Virchows Arch       Date:  2004-02-04       Impact factor: 4.064

9.  Effect of nicotinamide on early graft failure following intraportal islet transplantation.

Authors:  Da-Yeon Jung; Jae Berm Park; Sung-Yeon Joo; Jae-Won Joh; Choon-Hyuck Kwon; Ghee-Young Kwon; Sung-Joo Kim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

10.  Effects of poly (ADP-ribose) synthetase inhibitor on B-cells of a canine pancreas after massive pancreatectomy.

Authors:  K Sugiyama; Y Yonemura; H Okamoto
Journal:  Int J Pancreatol       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.